Eyedeal Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
as on 23-12-2024
- Paid Up Capital ₹ 0.80 M
as on 23-12-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -19.52%
(FY 2020)
- Profit -6.32%
(FY 2020)
- Ebitda -18.44%
(FY 2020)
- Net Worth 22.48%
(FY 2020)
- Total Assets 10.09%
(FY 2020)
About Eyedeal Pharma
The Corporate was formerly known as Eye Care Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 0.80 M, as per Ministry of Corporate Affairs (MCA) records.
Tanaji More, Maya Veer, Venukumar Rangu, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2012PTC235005
- Company No.
235005
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Latur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eyedeal Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tanaji More  | Director | 15-Mar-2016 | Current |
| Maya Veer | Additional Director | 23-May-2016 | Current |
| Venukumar Rangu | Director | 27-Aug-2012 | Current |
| Shivaji Kalge | Director | 27-Aug-2012 | Current |
| Vikas Bhingore | Director | 15-Mar-2016 | Current |
Financial Performance of Eyedeal Pharma.
Eyedeal Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 19.52% decrease. The company also saw a slight decrease in profitability, with a 6.32% decrease in profit. The company's net worth Soared by an impressive increase of 22.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eyedeal Pharma?
In 2020, Eyedeal Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eyedeal Pharma?
Eyedeal Pharma has a workforce of 15 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eyedeal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eyedeal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
